RxDoctor Payments Data

Timothy Graubert, MD

Medical Oncology · Saint Louis, MONPI 1073531703

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $240 of the $398 with a category attached, or 60.2%. Biogen accounts for 60.2% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for medical oncology clinicians in MO, where the typical reported total is $3,595.

$398in general payments, 2019–2025

Across 3 payments — averaging $132.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biogen$240
  • AstraZeneca$158
$474,813in research payments, 2019–2025

Across 3 payments — averaging $158,271 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Astrazeneca UK Limited$475K

What the payments were for

  • Consulting fees$24060%
  • Travel & lodging$9223%
  • Food & beverage$6717%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Biogen1$240
AstraZeneca2$158

How this compares

$398 in reported general payments places this provider in the 25th percentile of 144 medical oncology providers in Missouri.

See all medical oncology providers in Missouri

Medicare billing

Part B allowed, 2024
$16,675
Medicare patients
26
Services billed
135

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other medical oncology in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →